Autoimmune Tubulopathies
Journal of the American Society of Nephrology · 2025-04 · 36 (4) · 706-712
DOI: 10.1681/asn.0000000628 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 09.01.2025. Verfasst von Pascal Houillier und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité, Paris, France; CNRS ERL 8228 - Laboratoire de Physiologie Rén…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Kidney Diseases, Kidney Tubules. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fondation pour la Recherche Médicale, Agence Nationale de la Recherche, Filière de santé OSCAR.
Abstract (Originalsprache)
The renal tubule and collecting duct express a large number of proteins, all having putative immunoreactive motives. Therefore, all can be the target of pathogenic autoantibodies. However, autoimmune tubulopathies seem to be rare, and we hypothesize that they are underdiagnosed. This review summarizes the current knowledge on autoimmune tubulopathies. We elected to classify tubulopathies according to the segment that is targeted because this determines, at least in part, the phenotypic presentation. In the proximal tubule, autoantibodies can cause anti-brush border antibody disease, renal Fanconi syndrome, renal proximal tubular acidosis, or tubulointerstitial nephritis and uveitis syndrome. Autoantibodies targeting the thick ascending limb of the loop of Henle can cause either acquired Bartter syndrome or hypomagnesemia with hypercalciuria, whereas autoantibodies targeting the distal convoluted tubule can cause acquired Gitelman syndrome. Finally, renal distal tubular acidosis or nephrogenic diabetes insipidus can be caused by autoantibodies targeting the collecting duct. In most instances, the characterization of the autoantibodies remains incomplete and the pathogenesis of the disease obscure. We believe it is important to increase the awareness of physicians regarding autoantibody-mediated tubular diseases to have a better estimation of the prevalence and to improve the care to patients. A research effort to increase the understanding of the pathogenesis of autoantibodies-mediated tubular diseases is also hoped for.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité, Paris, France; CNRS ERL 8228 - Laboratoire de Physiologie Rénale et Tubulopathies, Paris, France; Assistance Publique-Hôpitaux de P…
ORCID-Profile: Pascal Houillier, Caroline Prot-Bertoye
Förderung
- Fondation pour la Recherche Médicale
- Agence Nationale de la Recherche
- Filière de santé OSCAR
- Filière de santé ORKID
Zitieren
APA
Houillier, P., & Prot-Bertoye, C. (2025). Autoimmune Tubulopathies. Journal of the American Society of Nephrology, 36(4), 706-712. https://doi.org/10.1681/asn.0000000628
Vancouver
Houillier P, Prot-Bertoye C. Autoimmune Tubulopathies. Journal of the American Society of Nephrology. 2025;36(4):706-712. doi:10.1681/asn.0000000628
BibTeX
@article{Houillier2025,
author = {Houillier, Pascal and Prot-Bertoye, Caroline},
title = {Autoimmune Tubulopathies},
journal = {Journal of the American Society of Nephrology},
year = {2025},
volume = {36},
number = {4},
pages = {706--712},
doi = {10.1681/asn.0000000628}
}
EUVIMED